Business · 27/12/2016Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Psychopharmacologic Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of the Psychopharmacologic Drugs Advisory Committee to provide advice on FDA's regulatory issues, following a request from the committee to discuss recent developments in the field of psychopharmacology.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →